Novartis Oncology
Novartis Oncology
     
Juvenile Myelomonocytic Leukemia (JMML)

What is juvenile myelomonocytic leukemia?
Juvenile myelomonocytic (my-eh-lo-mah-no-SIT-ik) leukemia (loo-KEE-me-ah)”JMML”is a rare type of childhood leukemia in which too many immature white blood cells are made in the bone marrow. These immature white blood cells are called "blasts."

What does JMML do to a person's body?
Over time, the blasts crowd out the red blood cells and platelets. People with JMML may develop serious infections or anemia, or they may bleed too easily. In people with JMML, cancer cells often spread into tissues, such as the skin, lung, and intestines.

How common is JMML?
JMML occurs in infants, young children, and occasionally adolescents. It affects only about 1 of every 1 million children under the age of 14 each year. It occurs more commonly in boys than in girls.

What causes JMML?
The cause is unknown. The actions of the bone marrow are complex and controlled by many factors, including the genes. Recent scientific studies have found a genetic change in some people with JMML that results in a combination of 2 individual genes. This new "fusion gene" creates a protein called a kinase (KY-nase) that causes some blood cells to multiply.

  Print This Page



Disclaimer: This is an international website dedicated to rare diseases, and intended for patients outside the US. The information on this site is not country-specific and may contain information that is outside the approved indications in the country in which you are located.
About Rare Diseases  |  DFSP  |  HES / CEL  |  Myelodysplastic / Myeloproliferative Diseases  |  Resources
Contact  |  Sitemap  |  Privacy
Use of this website is subject to our Terms of Use
© Novartis AG